Drug Benefits & Interchangeability Formulary

The Manitoba Drug Benefits and Interchangeability Formulary lists therapeutically effective drugs of proven high quality that have been approved as eligible benefits under the Pharmacare drug benefit program.  It also includes a list of interchangeable drugs.  It is compiled with the advice of the Manitoba Drug Standards and Therapeutics Committee, assisted by Manitoba Health staff and outside consultants.  The Minister of Health gives the final approval for benefits under the Pharmacare drug benefit program.

Updates to the Manitoba Formulary are made available every three to four months by bulletin and via this website.  Copies of the Manitoba Formulary and the updates are also available at the Queen’s Printer (Manitoba) Statutory Publications, 200 Vaughan Street, Winnipeg, Manitoba, R3C 1T5, telephone (204) 945-3101 in Winnipeg, toll free 1-800-321-1203, fax (204) 945-7172. Note: In the case of discrepancies between the versions of documents on this website and the official versions as published by the Queen’s Printer (Manitoba) Statutory Publications, the official versions will prevail.

Each new Formulary has three components:  a new Bulletin, a revised Specified Drugs Regulation (Parts 1 and 2) made under The Prescription Drugs Cost Assistance Act, and a revised Manitoba Drug Interchangeability Formulary.  A listing of pharmaceutical manufacturer abbreviations is also provided below.

These documents require knowledgeable interpretation and are intended primarily for use by professional health care practitioners, pharmacies, hospitals, and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.

---

Manitoba Drug Interchangeability Formulary Regulation
This regulation includes a list of interchangeable drugs, categories and prices under The Pharmaceutical Act. Please note that Manitoba Pharmacare will reimburse only up to the level of the lowest price in an interchangeable category for those interchangeable drugs which are Pharmacare benefits.
Effective: Sept. 9, 2010

Bulletin #64
Amendments to the Manitoba Drug Benefits and Interchangeability Formulary. 
Effective: September 9, 2010

Part 3: Exception Drug Status (EDS)
Certain drugs are approved for coverage under the Exception Drug Status (EDS) Program when they meet specific criteria and upon review and recommendation of the Manitoba Drug Standards and Therapeutics Committee (MDSTC).
Revised: September 9, 2010

Correct Quantities for PDP Claim Submissions
This document lists correct quantities for various categories of medications and for a number
of specific medications.

Specified Drugs Regulation
This is the regulation that provides for the benefit lists of specified drugs under the Prescription Drugs Cost Assistance Act. It lists the drugs and criteria for eligibility for the Manitoba Pharmacare program.
Effective: March 26, 2010

---

Notice to Pharmacists and Prescribers Re: Mirapex and Generic Pramipexole
Please note that Mirapex, Novo-Pramipexole and pms-Pramipexole are benefits through Provincial Drug Programs only when prescribed for the treatment of idiopathic Parkinson’s disease.

Manufacturer Abbreviations
An index of pharmaceutical manufacturer abbreviations used in the Manitoba Drug Interchangeability Formulary. 8 pages.
Revised: August 2010

Product Identification Number listing
A product identification listing for non-prescription products. 6 pages.
Revised: August 2010

---

(Veuillez noter que les documents sont offert en anglais seulement.)